Yumin Wan
Corporate Officer/Principal bij Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Profiel
Yumin Wan is currently the Vice President at Jiangsu Alphamab Biopharmaceuticals Co., Ltd.
Prior to this, from 2019 to 2021, Mr. Wan worked as the VP-Government Affairs & Public Relations at Alphamab Oncology.
Mr. Wan completed their graduate degree from China Agricultural University in 2000 and their undergraduate degree from Nanjing University in 1993.
Actieve functies van Yumin Wan
Bedrijven | Functie | Begin |
---|---|---|
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Jiangsu Alphamab Biopharmaceuticals Co., Ltd Pharmaceuticals: MajorHealth Technology Part of Suzhou Alphamab Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd is a company that manufactures and distributes therapeutics for cancer treatment. Jiangsu Alphamab Biopharmaceuticals Co., Ltd is based in Suzhou, China. The Chinese company was founded in 2015 by Ting Xu. Ting Xu has been the CEO since 2015. | Corporate Officer/Principal | - |
Eerdere bekende functies van Yumin Wan
Bedrijven | Functie | Einde |
---|---|---|
ALPHAMAB ONCOLOGY | Public Communications Contact | 01-05-2021 |
Opleiding van Yumin Wan
Nanjing University | Undergraduate Degree |
China Agricultural University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ALPHAMAB ONCOLOGY | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Jiangsu Alphamab Biopharmaceuticals Co., Ltd Pharmaceuticals: MajorHealth Technology Part of Suzhou Alphamab Co., Ltd., Jiangsu Alphamab Biopharmaceuticals Co., Ltd is a company that manufactures and distributes therapeutics for cancer treatment. Jiangsu Alphamab Biopharmaceuticals Co., Ltd is based in Suzhou, China. The Chinese company was founded in 2015 by Ting Xu. Ting Xu has been the CEO since 2015. | Health Technology |